1. Home
  2. WPRT vs LIXT Comparison

WPRT vs LIXT Comparison

Compare WPRT & LIXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Westport Fuel Systems Inc

WPRT

Westport Fuel Systems Inc

HOLD

Current Price

$2.13

Market Cap

30.7M

Sector

Industrials

ML Signal

HOLD

Logo Lixte Biotechnology Holdings Inc.

LIXT

Lixte Biotechnology Holdings Inc.

HOLD

Current Price

$3.48

Market Cap

25.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WPRT
LIXT
Founded
1995
2005
Country
Canada
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.7M
25.4M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
WPRT
LIXT
Price
$2.13
$3.48
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$4.50
N/A
AVG Volume (30 Days)
112.3K
88.8K
Earning Date
11-10-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$290,323,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
140.81
N/A
52 Week Low
$1.54
$0.64
52 Week High
$4.77
$6.26

Technical Indicators

Market Signals
Indicator
WPRT
LIXT
Relative Strength Index (RSI) 59.12 49.25
Support Level $2.05 $3.04
Resistance Level $2.31 $3.53
Average True Range (ATR) 0.12 0.32
MACD -0.00 0.03
Stochastic Oscillator 48.00 67.85

Price Performance

Historical Comparison
WPRT
LIXT

About WPRT Westport Fuel Systems Inc

Westport Fuel Systems Inc is an organization engaged in the engineering, manufacturing, and supply of alternative fuel systems and components for transportation applications. It has three operating segments; the Original Equipment Manufacturers segment-design, manufacture, and sell alternative fuel systems, components and electronics, and related engineering services, to OEMs that serve light-duty, medium-duty, and heavy-duty customers, the Independent Aftermarket segment includes IAM products, conversion kits, and components allow for the conversion of vehicles after being sold to the end-user through a network of dealers and installers, and Corporate includes public company activities, corporate oversight, financing and capital allocation.

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

Share on Social Networks: